Cara Therapeutics Inc. buy Needham & Company LLC
Start price
08.08.23
/
50%
€2.60
Target price
08.08.24
€20.10
Performance (%)
-74.25%
Price
10.05.24
€0.67
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL for Cara Therapeutics Inc. is performing very badly with a performance of -74.25%. This prediction currently runs until 08.08.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cara Therapeutics Inc. | -7.756% | -7.756% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by Needham___Company_LL for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
Ratings data for CARA provided by MarketBeat
Stopped prediction by Needham___Company_LL for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.75
10.04.24
10.04.24
€4.64
10.04.25
10.04.25
-10.36%
10.05.24
10.05.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.87
28.03.24
28.03.24
€4.62
28.03.25
28.03.25
-23.14%
10.05.24
10.05.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.78
05.03.24
05.03.24
€4.61
05.03.25
05.03.25
-14.18%
10.05.24
10.05.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.51
22.01.24
22.01.24
€4.59
22.01.25
22.01.25
30.59%
10.05.24
10.05.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.56
18.12.23
18.12.23
€5.50
18.12.24
18.12.24
18.61%
10.05.24
10.05.24
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.32
04.04.23
04.04.23
€20.09
04.04.24
04.04.24
-81.49%
05.04.24
05.04.24